5-fluorouracil, Calcium folinate and Irinotecan
Sponsors
Hutchison Medipharma Limited, Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Conditions
Advanced Neuroendocrine CarcinomaNeuroendocrine Carcinoma
Phase 3
A Phase 3 Study to Evaluate Surufatinib Plus Toripalimab in the Treatment of Advanced Neuroendocrine Carcinoma
NCT05015621
Start: 2021-09-18End: 2025-05-31Target: 194Updated: 2023-12-13
A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine Carcinoma
Not yet recruitingNCT07595913
Start: 2026-07-01End: 2028-12-01Target: 240Updated: 2026-05-19